Haemonetics (HAE) Net Margin (2009 - 2026)

Haemonetics has reported Net Margin for 18 years, with the latest figure at 9.72% in Q2 2026.

• On a quarterly basis, Net Margin fell 87.0% year-over-year to 9.72% in Q2 2026; TTM through Jun 2026 was 7.12%, a 501.0% decrease from a year earlier, with the FY2026 full-year figure at 7.29%, down 503.0% from the prior year.
• Net Margin was 9.72% for Q2 2026 at Haemonetics, up from 5.81% in the prior quarter.
• The five-year high for Net Margin was 17.54% in Q1 2025, with the low at 5.81% in Q1 2026.
• Average Net Margin over 5 years is 9.32%, with a median of 9.78% recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Net Margin surged 1159 bps in 2025, then plunged 2335 bps in 2026.
• Over 5 years, Net Margin stood at 10.78% in 2022, then declined by 14 bps to 9.29% in 2023, then advanced by 16 bps to 10.76% in 2024, then grew by 23 bps to 13.2% in 2025, then fell by 26 bps to 9.72% in 2026.
• The last three Net Margin figures came in at 9.72% (Q2 2026), 5.81% (Q1 2026), and 13.2% (Q4 2025), per Business Quant data.